Drugs With No Patents And No Competition: Here’s Why

Aggressive generic delay practices are troubling because, unlike patent exclusivity, they do not promote any public interest Increasing the costs of drugs has emerged as a core strategy for pharmaceutical… The post Drugs With No Patents And No Competition: Here’s Why appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: